INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,665 Cr | ₹1,817 Cr | ₹1,669 Cr | ₹1,541 Cr | ₹1,242 Cr |
What is the latest Revenue of INDOCO REMEDIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹1,665 Cr |
| Mar2024 | ₹1,817 Cr |
| Mar2023 | ₹1,669 Cr |
| Mar2022 | ₹1,541 Cr |
| Mar2021 | ₹1,242 Cr |
How is Revenue of INDOCO REMEDIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,665 Cr | -8.38 | |
| Mar2024 | ₹1,817 Cr | 8.91 | |
| Mar2023 | ₹1,669 Cr | 8.30 | |
| Mar2022 | ₹1,541 Cr | 24.10 | |
| Mar2021 | ₹1,242 Cr | - | |
Compare Revenue of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,004.4 Cr | 3.4% | -5.7% | -26.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹382,694.0 Cr | -2.3% | -7.3% | -12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,721.0 Cr | 0.8% | -5.8% | 4.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,016.0 Cr | 0.8% | 3.7% | 20.8% | Stock Analytics | |
| CIPLA | ₹106,946.0 Cr | 0.7% | -11.2% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,691.0 Cr | -1.4% | -3.8% | -1.3% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 3.4% |
-5.7% |
-26.1% |
| SENSEX | -0.1% |
-2.9% |
7.5% |
You may also like the below Video Courses